Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Articles written by Julie A. Vetalice & Rob Meyer

Orthobiologics for Fracture Repair, Knee Cartilage Defects: 3Q18 Study Highlights

by Julie A. Vetalice & Rob Meyer | Oct 2018

Bone Therapeutics (ALLOB® allogeneic bone cell therapy) and Histogenics (NeoCart® tissue-engineered knee implant) are two of the five companies we tracked that announced completed studies in the last three months. ... Read more »

b-ONE Ortho Gains FDA 510(k) Clearance for Total Hip

by Julie A. Vetalice & Rob Meyer | Sep 2018

The b-ONE™ cementless total hip system is the company’s first product following a US $20.0MM round of Series A financing. ... Read more »

Wright Medical’s Acquisition of Cartiva Offers Boost for Lower Extremity Business

by Julie A. Vetalice & Rob Meyer | Sep 2018

Cartiva’s Synthetic Cartilage Implant is used to treat arthritis in the great toe. Wright’s $435MM purchase of the technology (expected to close in 4Q18) enhances its position in the space by providing access to what company leadership described as a ~$420MM addressable market. ... Read more »

Stryker Moves to Strengthen Spine Business with $1.4 Billion Purchase of K2M

by Julie A. Vetalice & Rob Meyer | Sep 2018

K2M’s innovative technology platform will add a suite of complex spine solutions to Stryker’s core spine portfolio; K2M’s consistent support of additive manufacturing of devices could also benefit Stryker’s long-term growth. ... Read more »

First Two United States Patients Receive CartiHeal’s Agili-C Implants

by Julie A. Vetalice & Rob Meyer | Aug 2018

The Israeli startup develops implants to treat cartilage and osteochondral defects in traumatic and osteoarthritic joints; to date, 80 patients in Europe and Israel have been treated in the pivotal Agili-C IDE study. ... Read more »

Ortho Development Announces First Surgery Using Balanced Knee System in China

by Julie A. Vetalice & Rob Meyer | Aug 2018

The company’s BKS features implants and instrumentation that address primary and revision procedures. A patented locking mechanism is designed to minimize micro-motion between the plastic tibial insert and titanium tibial baseplates. ... Read more »

HAPPE Spine Latest Company to Manufacture PEEK Devices in Novel Ways

by Julie A. Vetalice & Rob Meyer | Aug 2018

The company was formed by Genesis Innovation Group with investments from cultivate(MD) Capital Funds I and II, and is based on the work of Ryan K. Roeder, Ph.D., and researchers from the University of Notre Dame that began over 10 years ago. ... Read more »

Cerapedics Enrolls Patients in P-15L Peptide-Enhanced Bone Graft IDE Trial

by Julie A. Vetalice & Rob Meyer | Aug 2018

P-15L graft, a substitute for autologous bone, is based on synthetic small peptide technology and was developed to spur bone growth via cell attraction, attachment and activation. Cerapedics has enrolled the first of 364 patients in this IDE clinical trial. ... Read more »